Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(+)-Rutamarin alcohol is a naturally occurring small molecule classified as a furanocoumarin derivative within the psoralen family. It is found in certain plant species such as Clausena anisata and Esenbeckia almawillia. The compound has been studied primarily for its cytotoxic activity against cancer cell lines and other potential biological effects. Its mechanism of action is not fully elucidated but may involve modulation of cellular pathways related to apoptosis and cell proliferation. There are no approved therapeutic indications or marketed formulations for this compound; it remains an experimental agent with research interest focused on its bioactivity profile[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (+)-rutamarin alcohol.